Injections, applications/preparation

GRAS listed. Accepted in the UK for use in certain food applications. Included in the FDA Inactive Ingredients Guide (dental preparations, IV injections, ophthalmic preparations, oral capsules and tablets, otic, topical, transdermal, and vaginal preparations). Included in nonparenteral medicines licensed in the UK. Included in the Canadian List of Acceptable Non-medicinal Ingredients. 

Turbulent flow chromatography is a direct-inject sample-preparation technique that is accomplished on a special chromatography column. The technique has some applicability toward plasma and serum. The special column combines large particle (50 lm) and frit size (20 lm) with high flow rate (5 to 10 mL/ min) to achieve eddies and nonlaminar flow. Under this arrangement, improved... 

While it is not a chromatographic issue per se, pre-injection sample preparation, nevertheless, is an important consideration in the successful application of a complete analytical process. This fact is borne out in the observation that recent technological advances in polymer characterization focus not only on the... 

The actual loading capacity always depends on the sample composition and the separation problem. As a rule the volume of the loaded sample should not exceed 5% of the column volume. However, this recommendation is valid only for preparative runs. For analytical applications when a high resolution is needed, the volume of the injected sample should be about 1% of the total column volume or even less. For a preparative run on a 1000 X 200-mm column (bed height 60 cm), two different sample volumes were injected. If the sample volume is 0.3% of the total bed volume, the separation is more efficient... 

Obviously, if you wish to treat a skin condition or infection, a preparation that can be applied topically would be the preferred option. Similarly, inhalation would be the first choice if trying to treat a pulmonary or bronchial condition, such as asthma. Dermal application would also be the first choice for localized tissue treatments (e.g. muscle injury), provided that the drug can be absorbed through the skin. However, in most other situations it is necessary for drugs to enter the bloodstream in order for them to be transported to their site of action. This is most commonly achieved by ingestion, or by intravenous (i.v.), intramuscular (i.m.) or subcutaneous (s.c.) injection when the oral route is not suitable. 

For many drug delivery applications, the preferred method of delivery of the dosage form is by injection. For controlled release applications, the most frequently used approach to allow this method of administration is to prepare microspheres of the polymer containing the drug to be delivered. Several different techniques have been developed for the preparation of microspheres from polyanhydrides. 

I also have another question. When you compare release data from a slice preparation where it is in one application with discrimination data, are you comparing a creature that has received hundreds of injections every other day, on the average 1 do not know what your protocol looks like, but 1 presume every other day is a drug and every other day is a control condition. Here you have an acute preparation and the relationship, of course, is quite tenuous. 

---